Germline AGO2 Mutations Impair RNA Interference and Human Neurological Development

ARGONAUTE-2 and associated miRNAs form the RNA-induced silencing complex (RISC), which targets mRNAs for translational silencing and degradation as part of the RNA interference pathway. Despite the essential nature of this process for cellular function, there is little information on the role of RISC components in human development and organ function. We identify 13 heterozygous mutations in AGO2 in 21 patients affected by disturbances in neurological development. Each of the identified single amino acid mutations result in impaired shRNA-mediated silencing. We observe either impaired RISC formation or increased binding of AGO2 to mRNA targets as mutation specific functional consequences. The latter is supported by decreased phosphorylation of a C-terminal serine cluster involved in mRNA target release, increased formation of dendritic P-bodies in neurons and global transcriptome alterations in patient-derived primary fibroblasts. Our data emphasize the importance of gene expression regulation through the dynamic AGO2-RNA association for human neuronal development.

Citing Articles

Optical genome mapping to decipher the chromosomal aberrations in families seeking for preconception genetic counseling.

Yin K, Li M, Zhang H, Chang J, Qi Q, Zhou X Sci Rep. 2025; 15(1):2614.

PMID: 39838026 PMC: 11751393. DOI: 10.1038/s41598-025-86828-9.

Inorganic arsenic modulates cell apoptosis by regulating Argonaute 2 expression via the p53 pathway.

Du K, Shu J, Wu J, Liu N, Ma H, Jiang J Toxicol Res (Camb). 2025; 14(1):tfae231.

PMID: 39802611 PMC: 11711588. DOI: 10.1093/toxres/tfae231.

DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.

Lessel I, Baresic A, Chinn I, May J, Goenka A, Chandler K Am J Hum Genet. 2025; 112(2):394-413.

PMID: 39798569 PMC: 11866971. DOI: 10.1016/j.ajhg.2024.12.012.

TRBP2, a Major Component of the RNAi Machinery, Is Subjected to Cell Cycle-Dependent Regulation in Human Cancer Cells of Diverse Tissue Origin.

Theotoki E, Kakoulidis P, Velentzas A, Nikolakopoulos K, Angelis N, Tsitsilonis O Cancers (Basel). 2024; 16(21).

PMID: 39518139 PMC: 11545598. DOI: 10.3390/cancers16213701.

MicroRNA and Rare Human Diseases.

Goel H, Goel A Genes (Basel). 2024; 15(10).

PMID: 39457367 PMC: 11507005. DOI: 10.3390/genes15101243.

References

Jung S, Kim E, Hwang W, Shin S, Song J, Hohng S . Dynamic anchoring of the 3'-end of the guide strand controls the target dissociation of Argonaute-guide complex. J Am Chem Soc. 2013; 135(45):16865-71. DOI: 10.1021/ja403138d. View

Wu L, Belasco J . Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell. 2008; 29(1):1-7. DOI: 10.1016/j.molcel.2007.12.010. View

Kwak P, Tomari Y . The N domain of Argonaute drives duplex unwinding during RISC assembly. Nat Struct Mol Biol. 2012; 19(2):145-51. DOI: 10.1038/nsmb.2232. View

Lessel D, Ozel A, Campbell S, Saadi A, Arlt M, McSweeney K . Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations. Hum Genet. 2018; 137(11-12):921-939. PMC: 6652186. DOI: 10.1007/s00439-018-1957-1. View

Storchel P, Thummler J, Siegel G, Aksoy-Aksel A, Zampa F, Sumer S . A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function. EMBO J. 2015; 34(17):2237-54. PMC: 4585461. DOI: 10.15252/embj.201490643. View

Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91. PMC: 5018207. DOI: 10.1038/nature19057. View

Walters G, Gustafsson O, Sveinbjornsson G, Eiriksdottir V, Agustsdottir A, Jonsdottir G . MAP1B mutations cause intellectual disability and extensive white matter deficit. Nat Commun. 2018; 9(1):3456. PMC: 6110722. DOI: 10.1038/s41467-018-05595-6. View

Lasser M, Tiber J, Lowery L . The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders. Front Cell Neurosci. 2018; 12:165. PMC: 6010848. DOI: 10.3389/fncel.2018.00165. View

Vasudevan S, Tong Y, Steitz J . Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007; 318(5858):1931-4. DOI: 10.1126/science.1149460. View

10.

Liu J, Carmell M, Rivas F, Marsden C, Thomson J, Song J . Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004; 305(5689):1437-41. DOI: 10.1126/science.1102513. View

11.

Hauptmann J, Dueck A, Harlander S, Pfaff J, Merkl R, Meister G . Turning catalytically inactive human Argonaute proteins into active slicer enzymes. Nat Struct Mol Biol. 2013; 20(7):814-7. DOI: 10.1038/nsmb.2577. View

12.

Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T . Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004; 15(2):185-97. DOI: 10.1016/j.molcel.2004.07.007. View

13.

Rajman M, Schratt G . MicroRNAs in neural development: from master regulators to fine-tuners. Development. 2017; 144(13):2310-2322. DOI: 10.1242/dev.144337. View

14.

Parker J, Roe S, Barford D . Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex. Nature. 2005; 434(7033):663-6. PMC: 2938470. DOI: 10.1038/nature03462. View

15.

Hempel M, Cremer K, Ockeloen C, Lichtenbelt K, Herkert J, Denecke J . De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment. Am J Hum Genet. 2015; 97(3):493-500. PMC: 4564986. DOI: 10.1016/j.ajhg.2015.08.003. View

16.

Schirle N, MacRae I . The crystal structure of human Argonaute2. Science. 2012; 336(6084):1037-40. PMC: 3521581. DOI: 10.1126/science.1221551. View

17.

Samocha K, Robinson E, Sanders S, Stevens C, Sabo A, McGrath L . A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014; 46(9):944-50. PMC: 4222185. DOI: 10.1038/ng.3050. View

18.

Song J, Smith S, Hannon G, Joshua-Tor L . Crystal structure of Argonaute and its implications for RISC slicer activity. Science. 2004; 305(5689):1434-7. DOI: 10.1126/science.1102514. View

19.

Gu S, Jin L, Huang Y, Zhang F, Kay M . Slicing-independent RISC activation requires the argonaute PAZ domain. Curr Biol. 2012; 22(16):1536-42. PMC: 3604743. DOI: 10.1016/j.cub.2012.06.040. View

20.

Zeitelhofer M, Karra D, Macchi P, Tolino M, Thomas S, Schwarz M . Dynamic interaction between P-bodies and transport ribonucleoprotein particles in dendrites of mature hippocampal neurons. J Neurosci. 2008; 28(30):7555-62. PMC: 6670838. DOI: 10.1523/JNEUROSCI.0104-08.2008. View